RECENT FUNDING
  1. Recent Funding
  2. Investors
  3. University of Oxford
U

University of Oxford portfolio

University of Oxford has 2 portfolio companies on record at Recent Funding, with 1 investment in the last 12 months.

Type: Investor.
Portfolio on Recent Funding: 2.
Deals, last 12 months: 1.
Capital in their rounds: $465M.
Latest deal: OMass Therapeutics · Oct 15, 2026.
About this page

Its most recent investment on record is OMass Therapeutics's $310M Series B+ round in October 2026, alongside Jefferson Life Sciences, Novo Holdings, Janus Henderson Investors and 6 others. By category, its portfolio leans toward Health and bio (2). It has co-invested with GV, Oxford Science Enterprises and Sanofi Ventures, most often GV (3 rounds).

What University of Oxford invests in

University of Oxford recent investments

How University of Oxford invests

StageDealsCapital in rounds
Series B+ 3 100%$465M
YearDealsCapital in rounds
2022 1 33%$100M
2025 1 33%$55M
2026 1 33%$310M

University of Oxford portfolio companies

CompanyRound with University of OxfordTotal raisedLatest raise
OOMass Therapeutics
Health and bio
Series B+ · $310M$422.51MOct 15, 2026
Series B+
UUltromics
Health and bio
Series B+ · $55M$111MAug 11, 2025
Series B+

Most frequent co-investors

Similar investors

Investors whose portfolios on Recent Funding center on the same category (Health and bio).

How this is counted

Share is of the 3 rounds on Recent Funding that name University of Oxford. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.

Portfolio companies are the companies on Recent Funding with a round that lists University of Oxford, which is a subset of its real portfolio. API: /api/v1/investors/university-of-oxford (get a free API key). More: the most active VC firms and new venture capital funds.